Exercise on GLP-1 Medications: The Best Workouts for Semaglutide and Tirzepatide

Starting a GLP-1 medication like semaglutide or tirzepatide is a significant step. The medication helps manage appetite, slow digestion, and drive meaningful weight loss. But exercise on semaglutide — how much, what kind, and when — is a question that keeps coming up in conversations between patients and providers.

Some people jump into intense workout routines alongside their GLP-1 program, hoping to accelerate results. Others back off significantly, uncertain how exercise interacts with the medication. Many land somewhere in the middle, unsure what approach actually works best.

The answer matters. Exercise during GLP-1 treatment influences not just how much weight you lose, but what kind of weight you lose. It affects how you feel day to day, how your cardiovascular health responds, and how sustainable your results are over the long term.

*Compounded semaglutide and tirzepatide are not FDA-approved. This article is for educational and informational purposes only and does not constitute medical advice. Individual results vary. Consult your licensed healthcare provider before starting any exercise program or making changes to your treatment plan.*

---

Why Exercise Matters on a GLP-1 Program

The short answer: GLP-1 medications reduce how much you eat. Exercise changes what your body does with that deficit.

When you create a caloric deficit, your body draws from stored energy: primarily fat, but also glycogen and some lean tissue. The proportion of fat versus muscle you lose depends significantly on how active you are and, specifically, whether you are doing resistance training. Physical activity tips the balance toward fat loss and helps preserve the lean tissue you want to keep.

Beyond body composition, exercise amplifies several of the systemic benefits that GLP-1 medications support. Insulin sensitivity improves with both GLP-1 therapy and physical activity. Cardiovascular function improves with both. The combination is not simply additive; it works through complementary mechanisms that reinforce each other.

The clinical data on semaglutide's cardiovascular effects is striking on its own. The SELECT trial, published in the *New England Journal of Medicine* (Lincoff et al., 2023, [PMID: 37952131](https://pubmed.ncbi.nlm.nih.gov/37952131/)), found that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease, even without a diabetes diagnosis. Exercise carries its own well-documented cardiovascular benefits. Together, they form a strong foundation for long-term health.

---

The Muscle Preservation Challenge

Rapid weight loss comes with a real tradeoff: some lean tissue loss alongside fat loss. This is covered in detail in the article on [semaglutide and muscle loss](/resources/semaglutide-muscle-loss-lean-mass), but the key point bears repeating here.

In the STEP 1 trial (Wilding et al., 2021, [PMID: 33567185](https://pubmed.ncbi.nlm.nih.gov/33567185/)), participants on semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks. A meaningful portion of that loss included lean mass, consistent with what happens during any significant caloric deficit. The same pattern appeared in tirzepatide trials (Jastreboff et al., 2022, [PMID: 35658024](https://pubmed.ncbi.nlm.nih.gov/35658024/)).

Lean mass matters for two reasons. First, muscle is metabolically active tissue; losing it reduces your resting metabolic rate, making long-term weight maintenance harder. Second, muscle supports physical function, strength, and quality of life, particularly as you age.

Exercise, and resistance training specifically, is the most effective tool for protecting lean mass during a caloric deficit. Research in *Current Sports Medicine Reports* (Westcott, 2012, [PMID: 22777332](https://pubmed.ncbi.nlm.nih.gov/22777332/)) found that resistance training consistently improved body composition across diverse populations, increasing lean mass and reducing fat mass even in the context of caloric restriction.

This makes resistance training the most important category of exercise for anyone on a GLP-1 program.

---

The Best Exercise Types for GLP-1 Users

Resistance Training: The Non-Negotiable

If you can only do one type of exercise on a GLP-1 program, make it resistance training.

Lifting weights, using resistance bands, performing bodyweight exercises, or doing machine-based work at a gym all send the same signal to your muscles: you need these. That signal stimulates muscle protein synthesis and counteracts the lean mass loss that comes with rapid weight reduction.

You do not need a gym membership for this to work. Two to three sessions per week covering the major muscle groups is a solid foundation. A simple structure:

• Lower body: squats, lunges, leg press, or step-ups
• Upper body pushing: push-ups, shoulder press, or bench press
• Upper body pulling: rows, lat pulldowns, or pull-ups
• Core: planks, dead bugs, or cable variations

Each session does not need to be long. Thirty to forty-five minutes, with three to four sets per movement, covers the basics effectively.

Progressive overload matters. As your body adapts, the stimulus decreases. Gradually increasing the weight, reps, or difficulty over time keeps the signal strong and continues driving muscle maintenance or modest muscle gain.

Walking and Low-Intensity Cardio

Walking is underrated as a tool on GLP-1 programs, particularly in the early weeks when energy levels may be lower and nausea can be a factor.

A sustained daily walk of 30 to 45 minutes adds meaningful caloric expenditure without the recovery demands of higher-intensity training. It supports cardiovascular health, improves insulin sensitivity, and carries low risk from a soreness and injury standpoint.

The American College of Sports Medicine position stand on exercise for weight management (Donnelly et al., 2009, [PMID: 19127177](https://pubmed.ncbi.nlm.nih.gov/19127177/)) recommends a progressive target of 150 to 250 minutes of moderate-intensity physical activity per week for clinically meaningful benefits. Walking at a brisk pace qualifies. If resistance training is your anchor, walking is an excellent complement.

Some people do well with structured cardio: cycling, rowing, swimming, or elliptical work. All of these are appropriate choices. The key is managing intensity so it does not compromise recovery and leave you too depleted to maintain the resistance training that drives lean mass preservation.

High-Intensity Interval Training: Useful, With Caveats

HIIT can be effective for cardiovascular fitness and metabolic health, and it is time-efficient. If you were doing HIIT before starting a GLP-1 program and you tolerate it well, there is no need to stop.

The caveats are worth noting. GLP-1 medications reduce caloric intake significantly. High-intensity training carries high energy demands and meaningful recovery requirements. If you are consistently underfueling, which is easy to do when appetite is suppressed, frequent HIIT can contribute to fatigue and make it harder to sustain training over time.

If you are new to exercise or new to a GLP-1 program, starting with walking and two to three resistance training sessions per week is a more sustainable entry point. HIIT can be layered in once your nutrition and recovery patterns are well established.

---

*Resistance training two to three times per week is the most effective strategy for preserving lean mass during GLP-1-assisted weight loss.*

---

Timing Your Workouts on GLP-1 Medications

GLP-1 medications slow gastric emptying, meaning food stays in your stomach longer than usual. Exercising too soon after eating can cause discomfort, nausea, or reflux, particularly in the early months of treatment or following a dose increase.

A few practical approaches that tend to work well:

Train before a large meal. Many people find morning exercise, before eating, sidesteps gastric discomfort entirely. It also takes advantage of the hours when nausea tends to be lower for most weekly injection schedules.

Allow at least two to three hours after eating. On days when you eat before training, giving your stomach time to empty reduces the likelihood of exercise-induced nausea.

Stay hydrated. Dehydration worsens nausea on GLP-1 medications. Drinking adequate water throughout the day, and sipping rather than gulping during exercise, supports comfort during workouts.

Weekly injection timing also plays a role. Most people experience the strongest appetite suppression and any mild side effects in the 24 to 72 hours following their injection. Scheduling harder training sessions later in the week, when side effects have typically eased, tends to produce better workouts and more consistent output.

---

Common Exercise Challenges on GLP-1 Programs

Low Energy in the First Weeks

Significant caloric restriction, even when driven by reduced appetite rather than willpower, is an adjustment your body takes time to adapt to. Some people feel lower energy in the first four to six weeks on a GLP-1 medication. This is normal and tends to improve.

If energy is low during this period, it is worth reviewing protein and total caloric intake. As covered in the [nutrition guide for semaglutide](/resources/what-to-eat-on-semaglutide), a target of 1.2 to 1.6 grams of protein per kilogram of body weight supports energy, muscle preservation, and recovery. Missing this consistently compounds the low-energy problem.

Low energy is not a reason to stop exercising entirely. Maintain consistency at a lower intensity if needed. A short walk still beats a skipped session.

Nausea During or After Exercise

Exercise-induced nausea is more likely when the stomach is not fully empty, when hydration is insufficient, or during high-intensity efforts. If this is a recurring problem:

• Shift training to a fasted or semi-fasted state
• Focus on lower-intensity, longer-duration exercise during dose increases
• Ensure hydration is adequate before and during workouts
• Discuss nausea management with your provider if it is persistent or severe

Getting Enough Protein to Support Training

This is the practical tension most GLP-1 users face. The medication meaningfully reduces appetite, which is the goal. But it can also make hitting protein targets feel difficult when you are eating less overall.

High-protein, lower-volume foods help: Greek yogurt, cottage cheese, eggs, chicken, fish, canned tuna, protein shakes, and edamame are practical options that deliver protein without requiring large portions. A protein shake post-workout is a straightforward way to close the gap on high-training days without adding significant volume to your meals.

---

How Much Exercise Is Actually Needed?

You do not need a demanding training schedule to benefit from exercise on a GLP-1 program. Research and clinical guidance converge on a practical minimum:

• Two to three resistance training sessions per week, 30 to 45 minutes each
• 150 minutes or more of moderate-intensity physical activity per week (walking counts)

This is achievable for most people, including those new to structured exercise. Starting at a level you can sustain consistently beats starting with ambition and stopping after two weeks.

More exercise is not always better, particularly if it outpaces your caloric intake and recovery capacity. The goal is consistency over months, not peak intensity in any single week.

---

What Exercise Cannot Do

One expectation worth addressing directly: exercise alone will not substitute for GLP-1 medication, and GLP-1 medication alone is not a reason to skip exercise.

Clinical research has consistently shown that exercise without dietary change produces modest weight loss at best. Conversely, GLP-1 medications without physical activity produce strong early weight loss but carry a higher risk of lean mass reduction and metabolic adaptation over time. The combination consistently outperforms either approach alone.

This is not a question of effort or discipline. It is about using the full toolkit available to you: the medication helps you eat less; exercise helps preserve what you want to keep and strengthens your cardiovascular system in the process.

---

The Bottom Line

Exercise on semaglutide or tirzepatide is not complicated, but it is important. Resistance training is the highest-priority activity because it directly counteracts lean mass loss during rapid weight reduction. Walking and moderate cardio support cardiovascular health and add to daily energy expenditure without heavy recovery demands.

Timing workouts around your injection schedule and eating patterns reduces the nausea and discomfort that some people experience, particularly in the early months of treatment. Protecting protein intake is the nutritional counterpart to consistent training: both are essential for the body composition outcomes that matter long-term.

The GLP-1 medication creates a powerful metabolic environment for weight loss. Exercise shapes how that weight loss affects your body, your health markers, and where you land a year from now.

Ready to explore your options? [Check your eligibility](/get-started) to speak with a Prescriva-affiliated provider about a treatment plan that fits your goals.

---

Sources

1. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. *N Engl J Med.* 2023;389(24):2221-2232. [PMID: 37952131](https://pubmed.ncbi.nlm.nih.gov/37952131/). doi:10.1056/NEJMoa2307563

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. *N Engl J Med.* 2021;384(11):989-1002. [PMID: 33567185](https://pubmed.ncbi.nlm.nih.gov/33567185/). doi:10.1056/NEJMoa2032183

1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. *N Engl J Med.* 2022;387(3):205-216. [PMID: 35658024](https://pubmed.ncbi.nlm.nih.gov/35658024/). doi:10.1056/NEJMoa2206038

1. Westcott WL. Resistance training is medicine: effects of strength training on health. *Curr Sports Med Rep.* 2012;11(4):209-216. [PMID: 22777332](https://pubmed.ncbi.nlm.nih.gov/22777332/). doi:10.1249/JSR.0b013e31825dabb8

1. Donnelly JE, Blair SN, Jakicic JM, et al. American College of Sports Medicine position stand: appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. *Med Sci Sports Exerc.* 2009;41(2):459-471. [PMID: 19127177](https://pubmed.ncbi.nlm.nih.gov/19127177/). doi:10.1249/MSS.0b013e3181949333

---

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any exercise program or making significant changes to your diet, exercise, or treatment plan.

Compounding Disclaimer: Compounded semaglutide and tirzepatide are not FDA-approved medications. Compounded drugs are not reviewed by the FDA for safety, efficacy, or quality. Compounded semaglutide is not the same as, equivalent to, or interchangeable with FDA-approved semaglutide products (Ozempic, Wegovy, or Rybelsus). Compounded tirzepatide is not the same as FDA-approved tirzepatide products (Mounjaro, Zepbound). Clinical research cited in this article refers to FDA-approved formulations and may not reflect outcomes from compounded versions.

Results Disclaimer: Individual results vary. Weight management outcomes depend on adherence to your prescribed treatment plan, diet, exercise, starting weight, and other individual health factors. Results are not guaranteed.

Provider Disclaimer: All medical services, including prescribing, are provided by independently licensed healthcare providers. Blue Oak Services LLC dba Prescriva is a management services organization and does not practice medicine or make clinical decisions.

Brand Disclaimer: Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Prescriva is not affiliated with, endorsed by, or sponsored by Novo Nordisk A/S or Eli Lilly and Company.